StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
35
This year
2
Publishing Date
2024 - 02 - 28
1
2024 - 01 - 30
1
2023 - 09 - 21
1
2023 - 09 - 18
1
2023 - 09 - 06
1
2023 - 08 - 23
1
2023 - 08 - 10
1
2023 - 06 - 19
1
2023 - 05 - 01
1
2023 - 04 - 12
1
2022 - 12 - 22
1
2022 - 10 - 05
1
2022 - 09 - 14
1
2022 - 09 - 05
1
2022 - 09 - 02
1
2022 - 06 - 29
1
2022 - 06 - 24
1
2022 - 06 - 20
1
2022 - 06 - 09
1
2022 - 05 - 11
1
2022 - 05 - 03
1
2022 - 04 - 25
1
2022 - 04 - 07
1
2022 - 03 - 28
1
2022 - 03 - 10
1
2022 - 02 - 14
1
2021 - 10 - 28
1
2021 - 10 - 25
1
2021 - 09 - 21
1
2021 - 08 - 26
1
2021 - 08 - 23
1
2021 - 07 - 30
1
2021 - 06 - 25
1
2021 - 06 - 23
1
2021 - 05 - 03
1
Sector
Communications
1
Consumer non-durables
3
Health technology
35
Manufacturing
9
N/a
1
Tags
Acne
11
Acquisition
3
Aesthetic
14
America
17
Application
4
Approval
8
Biocanada
42
Cancer
4
Care
6
Ces
4
Clinical-trials-phase-iii
4
Companies
26
Conference
11
Corporation
8
Covid
3
Deadline
24
Device
11
Disease
20
Drug
22
Earnings
14
Energy
7
Events
14
Expected
8
Eye
16
Fda
5
Financial results
4
Gastrointestinal
5
Global
36
Growing
12
Growth
63
Health
82
Injection
4
Ipo
5
Laser
9
Liver
7
Macular
8
Market
106
Meeting
4
Money
5
N/a
279
Offering
4
Patent
4
People
6
Pharma
4
Pharmaceuticals
7
Phase 3
6
Presentation
4
Program
4
Psoriasis
4
Report
28
Research
33
Results
31
Risk
6
Set
4
Skin
7
Study
4
Therapeutics
13
Treatment
35
Trial
11
Xipere
4
Entities
3m company
20
Abbott laboratories
57
Abbvie inc.
117
Accuray incorporated
18
Adamis pharmaceuticals corporation
19
Adial pharmaceuticals, inc
18
Alnylam pharmaceuticals, inc.
38
Amgen inc.
46
Arcutis biotherapeutics, inc.
24
Arrowhead pharmaceuticals, inc.
22
Astellas pharma inc
51
Astrazeneca plc
46
Bausch health companies inc.
35
Biogen inc.
41
Bioxcel therapeutics, inc.
19
Boston scientific corporation
21
Brainsway ltd.
39
Bridgebio pharma, inc.
18
Bristol-myers squibb company
93
Cns pharmaceuticals, inc.
26
Coherus biosciences, inc.
28
Ecolab inc.
47
Eli lilly and company
175
Fortress biotech, inc.
27
Gilead sciences, inc.
50
Glaxosmithkline plc
98
Horizon therapeutics public limited company
19
Hoth therapeutics, inc.
24
Incyte corporation
77
Intellia therapeutics, inc.
31
Ionis pharmaceuticals, inc.
19
Johnson & johnson
198
Karyopharm therapeutics inc.
27
Koninklijke philips n.v.
20
Medicinova, inc.
24
Medtronic plc
44
Merck & company, inc.
63
Moleculin biotech, inc.
28
Novartis ag
138
Novo nordisk a/s
34
Nrx pharmaceuticals inc
19
Orange
84
Perrigo company
19
Pfizer, inc.
74
Reata pharmaceuticals, inc.
28
Regeneron pharmaceuticals, inc.
58
Regenxbio inc.
25
Sanofi
281
Soligenix, inc.
19
Sorrento therapeutics, inc.
37
Takeda pharmaceutical company limited
51
Teleflex incorporated
19
Teva pharmaceutical industries ltd
76
Tg therapeutics, inc.
24
Tonix pharmaceuticals holding corp.
29
Ultragenyx pharmaceutical inc.
25
Verrica pharmaceuticals inc.
23
Vertex pharmaceuticals incorporated
27
Viatris inc.
45
Xylem inc.
35
Symbols
ABBV
7
ABT
3
ALBO
1
ALC
2
ALPMF
1
ALPMY
1
ARVL
1
ATAI
1
ATNX
1
BAX
1
BHC
35
BIIB
1
BMY
1
CAWW
1
CLSD
3
EVOTF
2
FNCTF
1
GLAXF
7
GSK
8
IMUN
1
INMD
1
IRWD
1
JNJ
7
LLY
3
MNK
1
MNKKQ
1
MNKPF
1
NBIX
1
NVS
14
NVSEF
11
PFE
2
PPRUF
1
PPRUY
1
PRGO
1
RBGLY
2
RBGPF
2
RGNX
3
SGMO
1
SNY
3
SNYNF
3
TAK
3
TEVJF
5
TKPHF
1
VTRS
6
Exchanges
Nasdaq
25
Nyse
35
Crawled Date
2024 - 02 - 28
1
2024 - 01 - 30
1
2023 - 09 - 21
1
2023 - 09 - 18
1
2023 - 09 - 07
1
2023 - 08 - 23
1
2023 - 08 - 10
1
2023 - 06 - 19
1
2023 - 05 - 01
1
2023 - 04 - 12
1
2022 - 12 - 22
1
2022 - 10 - 05
1
2022 - 09 - 14
1
2022 - 09 - 05
1
2022 - 09 - 02
1
2022 - 06 - 29
1
2022 - 06 - 24
1
2022 - 06 - 20
1
2022 - 06 - 09
1
2022 - 05 - 11
1
2022 - 05 - 03
1
2022 - 04 - 25
1
2022 - 04 - 07
1
2022 - 03 - 28
1
2022 - 03 - 10
1
2022 - 02 - 14
1
2021 - 10 - 28
1
2021 - 10 - 25
1
2021 - 09 - 21
1
2021 - 08 - 26
1
2021 - 08 - 23
1
2021 - 07 - 30
1
2021 - 06 - 25
1
2021 - 06 - 23
1
2021 - 05 - 03
1
Crawled Time
00:00
1
01:00
1
02:00
1
04:00
1
05:00
1
06:00
1
08:00
2
09:00
2
10:00
2
11:00
2
12:00
3
12:20
1
13:00
1
13:30
1
14:00
2
16:00
1
17:00
2
18:00
6
19:00
2
22:00
2
Source
www.biospace.com
8
www.prnewswire.com
27
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Treatment
entities :
Bausch health companies inc.
save search
Myopia and presbyopia treatment market size to grow by USD 7.94 billion from 2022 to 2027, Major Vendors include AbbVie Inc., Alcon Inc. and Arctic Vision, Technavio
Published:
2024-02-28
(Crawled : 17:00)
- prnewswire.com
FNCTF
|
News
|
$11.16
-20.84%
130
|
Communications
|
-4.86%
|
O:
-1.4%
H:
0.0%
C:
-0.01%
BHC
|
$8.56
0.35%
0.0%
2M
|
Health Technology
|
-7.08%
|
O:
0.11%
H:
2.23%
C:
0.11%
ALC
|
$79.57
-1.47%
0.0%
850K
|
Health Technology
|
-0.52%
|
O:
4.09%
H:
1.72%
C:
1.41%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
-5.16%
|
O:
0.6%
H:
0.02%
C:
-1.03%
abbvie
presbyopia
treatment
market
CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel for the Treatment of Acne Vulgaris Now Available in the U.S.
Published:
2024-01-30
(Crawled : 13:30)
- biospace.com/
BHC
|
$8.56
0.35%
0.0%
2M
|
Health Technology
|
2.4%
|
O:
-0.36%
H:
0.0%
C:
-1.33%
treatment
gel
acne
Scar Treatment Market size to grow by USD 13.17 billion from 2022-2027 | North America to account for 37% of market growth - Technavio
Published:
2023-09-21
(Crawled : 06:00)
- prnewswire.com
BHC
|
$8.56
0.35%
0.0%
2M
|
Health Technology
|
2.28%
|
O:
-1.2%
H:
2.79%
C:
1.82%
america
treatment
growth
market
Myopia and presbyopia treatment market to grow by USD 7.94 billion from 2022 to 2027 | Asia to account for 37% of market growth- Technavio
Published:
2023-09-18
(Crawled : 05:00)
- prnewswire.com
BHC
|
$8.56
0.35%
0.0%
2M
|
Health Technology
|
0.12%
|
O:
-1.06%
H:
0.59%
C:
-0.71%
ALC
|
$79.57
-1.47%
0.0%
850K
|
Health Technology
|
-1.43%
|
O:
-0.85%
H:
0.38%
C:
-0.06%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
11.06%
|
O:
0.33%
H:
0.0%
C:
0.0%
presbyopia
treatment
asia
market
Global Huntington's Disease Treatment Market Analysis Report 2023-2030: Novel Approaches, Regional Trends, and Research Endeavors
Published:
2023-09-06
(Crawled : 00:00)
- prnewswire.com
BHC
|
$8.56
0.35%
0.0%
2M
|
Health Technology
|
2.03%
|
O:
-0.96%
H:
1.93%
C:
1.69%
SGMO
|
News
|
$0.4911
-5.72%
-6.07%
1.2M
|
Health Technology
|
-48.0%
|
O:
0.0%
H:
3.0%
C:
-4.77%
NBIX
|
News
4
|
$138.91
-0.84%
-0.85%
880K
|
Health Technology
|
27.16%
|
O:
0.44%
H:
0.23%
C:
-1.97%
disease
report
treatment
research
global
market
Global Urea Cycle Disorders Treatment Industry 2023-2027: Insights into Enzyme Deficiency Types, Treatment Options, Routes of Administration, and Distribution Channels
Published:
2023-08-23
(Crawled : 18:00)
- prnewswire.com
RBGPF
|
News
|
$52.06
6.46%
4.8K
|
Consumer Non-Durables
|
-28.31%
|
O:
-1.89%
H:
1.87%
C:
1.22%
RBGLY
|
News
|
$10.59
-2.05%
850K
|
Manufacturing
|
-24.95%
|
O:
-0.56%
H:
0.81%
C:
-0.07%
BHC
|
$8.56
0.35%
0.0%
2M
|
Health Technology
|
4.53%
|
O:
-0.49%
H:
1.11%
C:
-0.62%
ABT
|
News
|
$106.89
-0.65%
-0.22%
5.1M
|
Health Technology
|
1.85%
|
O:
-0.59%
H:
0.0%
C:
0.0%
urea
distribution
disorders
treatment
global
Environmental Factors and Advancements in Immunotherapies Propel Growth of Global Allergy Treatment Market to 2027
Published:
2023-08-10
(Crawled : 10:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
11.85%
|
O:
0.63%
H:
0.0%
C:
-2.67%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
13.78%
|
O:
2.5%
H:
0.0%
C:
-0.11%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-4.34%
|
O:
0.13%
H:
0.72%
C:
-0.18%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-13.35%
|
O:
0.75%
H:
1.13%
C:
-1.05%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
17.23%
|
O:
0.0%
H:
0.61%
C:
-0.28%
BHC
|
$8.56
0.35%
0.0%
2M
|
Health Technology
|
-1.04%
|
O:
-0.23%
H:
1.22%
C:
-2.21%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
12.59%
|
O:
0.41%
H:
1.08%
C:
0.16%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-10.6%
|
O:
1.52%
H:
1.05%
C:
0.47%
propel
treatment
global
growth
market
Global Constipation Treatment Markets to 2030: A $27.5 Billion Industry Opportunity with Laxatives Accounting for $12.3 Billion
Published:
2023-06-19
(Crawled : 17:00)
- prnewswire.com
MNKPF
|
$17.25
|
n/a
|
Email alert
Add to watchlist
BHC
|
$8.56
0.35%
0.0%
2M
|
Health Technology
|
Email alert
Add to watchlist
MNKKQ
|
$0.02
|
Manufacturing
|
Email alert
Add to watchlist
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
Email alert
Add to watchlist
ALBO
|
$44.15
-0.23%
0.39%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
Email alert
Add to watchlist
MNK
|
$0.3402
-0.06%
540K
|
n/a
|
Email alert
Add to watchlist
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
treatment
global
Ortho Dermatologics Announces U.S. Food and Drug Administration New Drug Application Filing Acceptance for Investigational Acne Treatment IDP-126 Gel
Published:
2023-05-01
(Crawled : 12:20)
- biospace.com/
BHC
|
$8.56
0.35%
0.0%
2M
|
Health Technology
|
15.74%
|
O:
0.14%
H:
3.66%
C:
1.76%
idp-126
drug
food
treatment
gel
application
acne
Ewing's Sarcoma Treatment Market size to grow by USD 302.5 million from 2021 to 2026, Driven by the growing awareness about and funding for Ewing's sarcoma - Technavio
Published:
2023-04-12
(Crawled : 08:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
4.49%
|
O:
1.63%
H:
0.0%
C:
-2.39%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
20.94%
|
O:
1.1%
H:
0.0%
C:
0.0%
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
14.63%
|
O:
0.71%
H:
0.3%
C:
-1.6%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
3.19%
|
O:
0.75%
H:
0.5%
C:
-0.05%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
10.41%
|
O:
1.15%
H:
0.39%
C:
-0.19%
BAX
|
$40.93
-0.22%
0.0%
2.2M
|
Health Technology
|
-4.36%
|
O:
0.47%
H:
0.8%
C:
-0.97%
BHC
|
$8.56
0.35%
0.0%
2M
|
Health Technology
|
11.94%
|
O:
1.31%
H:
0.26%
C:
-4.4%
treatment
growing
funding
market
First tazarotene lotion treatment for acne vulgaris, ARAZLO TM (tazarotene lotion, 0.045%), now available to patients through Quebec, Ontario, Alberta, Saskatchewan and federal NIHB public drug plans
Published:
2022-12-22
(Crawled : 13:00)
- biospace.com/
BHC
|
$8.56
0.35%
0.0%
2M
|
Health Technology
|
23.44%
|
O:
-1.3%
H:
0.73%
C:
-4.25%
treatment
drug
acne
Global Acne Drugs Market Report 2022: Development of Effective Therapeutics and Treatment Alternatives to Spur Further Growth
Published:
2022-10-05
(Crawled : 18:00)
- prnewswire.com
RBGPF
|
News
|
$52.06
6.46%
4.8K
|
Consumer Non-Durables
|
-22.24%
|
O:
-0.27%
H:
0.0%
C:
-2.06%
RBGLY
|
News
|
$10.59
-2.05%
850K
|
Manufacturing
|
-21.1%
|
O:
-1.25%
H:
0.47%
C:
-0.22%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-8.57%
|
O:
0.91%
H:
0.0%
C:
0.0%
BHC
|
$8.56
0.35%
0.0%
2M
|
Health Technology
|
13.13%
|
O:
-0.93%
H:
2.68%
C:
1.47%
treatment
global
report
therapeutics
acne
growth
market
Macular Degeneration Treatment Global Market to Reach $10.65 Billion by 2026 at a CAGR of 7.15%
Published:
2022-09-14
(Crawled : 10:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
27.09%
|
O:
-4.98%
H:
7.63%
C:
2.67%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
20.63%
|
O:
-0.55%
H:
0.42%
C:
-0.72%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
30.38%
|
O:
-0.6%
H:
0.41%
C:
-0.76%
BHC
|
$8.56
0.35%
0.0%
2M
|
Health Technology
|
15.9%
|
O:
0.41%
H:
11.64%
C:
6.22%
RGNX
|
$16.05
0.94%
0.93%
350K
|
Health Technology
|
-39.61%
|
O:
0.38%
H:
2.53%
C:
1.48%
treatment
global
macular
market
Global Treatment Resistant Depression Market to Surpass US$ 1,545.6 Million by 2030 - Coherent Market Insights
Published:
2022-09-05
(Crawled : 19:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
23.63%
|
O:
0.6%
H:
0.0%
C:
-4.59%
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
19.97%
|
O:
-2.93%
H:
10.14%
C:
3.79%
ATAI
|
$1.875
-4.82%
-5.07%
830K
|
Manufacturing
|
-54.82%
|
O:
1.61%
H:
0.45%
C:
-4.97%
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
20.21%
|
O:
0.42%
H:
0.0%
C:
-0.84%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-9.73%
|
O:
-1.1%
H:
0.0%
C:
0.0%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
29.48%
|
O:
-0.63%
H:
0.35%
C:
-0.57%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
145.26%
|
O:
0.54%
H:
3.26%
C:
1.28%
BHC
|
$8.56
0.35%
0.0%
2M
|
Health Technology
|
32.25%
|
O:
0.47%
H:
1.39%
C:
0.15%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
24.41%
|
O:
0.75%
H:
1.49%
C:
0.21%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
16.54%
|
O:
-1.35%
H:
0.0%
C:
0.0%
treatment
global
depression
market
8 MM Ulcerative Colitis Market Forecasts, Epidemiology & Pipeline Analysis 2022-2027: Novel Emerging Drugs will Shift the Inflammatory Bowel Disease (IBD) Treatment Paradigm
Published:
2022-09-02
(Crawled : 18:00)
- prnewswire.com
ARVL
|
News
|
$0.49
0.37%
2.5M
|
Manufacturing
|
-47.61%
|
O:
1.43%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-2.87%
|
O:
-0.15%
H:
0.29%
C:
-1.02%
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-43.56%
|
O:
0.24%
H:
0.13%
C:
-2.23%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
23.07%
|
O:
0.21%
H:
0.86%
C:
-0.99%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-7.43%
|
O:
2.55%
H:
0.0%
C:
0.0%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
139.07%
|
O:
0.32%
H:
0.04%
C:
-2.83%
BHC
|
$8.56
0.35%
0.0%
2M
|
Health Technology
|
29.44%
|
O:
1.06%
H:
1.35%
C:
-3.15%
treatment
disease
market
ulcerative colitis
Herpes Treatment Market size to grow by USD 723.04 Mn | Market Research Insights highlight increasing prevalence of herpes infection as Key Driver | Technavio
Published:
2022-06-29
(Crawled : 04:00)
- prnewswire.com
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
48.32%
|
O:
-9.17%
H:
0.0%
C:
0.0%
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
-28.91%
|
O:
-0.95%
H:
1.01%
C:
-3.54%
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
2.3%
|
O:
-1.49%
H:
0.09%
C:
-1.19%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
15.75%
|
O:
-0.68%
H:
0.0%
C:
0.0%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
-23.89%
|
O:
0.3%
H:
1.08%
C:
0.67%
BHC
|
$8.56
0.35%
0.0%
2M
|
Health Technology
|
-2.51%
|
O:
0.57%
H:
0.57%
C:
-3.3%
treatment
research
infection
market
Irritable Bowel Syndrome Treatment Market to Surpass US$ 3,902.9 Million by 2030 - Coherent Market Insights
Published:
2022-06-24
(Crawled : 18:00)
- prnewswire.com
ALPMF
|
News
|
$9.5
43.47%
1.2K
|
Health Technology
|
-39.7%
|
O:
0.99%
H:
0.0%
C:
-0.5%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
46.19%
|
O:
6.71%
H:
0.0%
C:
-0.1%
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-40.39%
|
O:
4.33%
H:
0.0%
C:
-2.44%
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-2.8%
|
O:
0.36%
H:
0.0%
C:
0.0%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
21.17%
|
O:
2.38%
H:
0.0%
C:
0.0%
BHC
|
$8.56
0.35%
0.0%
2M
|
Health Technology
|
17.33%
|
O:
5.78%
H:
13.91%
C:
13.78%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
14.24%
|
O:
1.57%
H:
0.0%
C:
0.0%
IRWD
|
$8.11
-2.41%
-2.47%
1.9M
|
Health Technology
|
-24.8%
|
O:
0.27%
H:
2.08%
C:
1.99%
treatment
market
The Worldwide Herpes Zoster Treatment Industry is Expected to Reach $303.4 Million by 2030
Published:
2022-06-20
(Crawled : 16:00)
- prnewswire.com
BHC
|
$8.56
0.35%
0.0%
2M
|
Health Technology
|
Email alert
Add to watchlist
PPRUY
|
News
|
$33.79
-0.11%
360K
|
Manufacturing
|
Email alert
Add to watchlist
ABT
|
News
|
$106.89
-0.65%
-0.22%
5.1M
|
Health Technology
|
Email alert
Add to watchlist
PPRUF
|
News
|
$340.0
37.56%
1.5K
|
Consumer Non-Durables
|
Email alert
Add to watchlist
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
Email alert
Add to watchlist
treatment
expected
Global Macular Degeneration Treatment Market Report (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
Published:
2022-06-09
(Crawled : 18:00)
- prnewswire.com
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
30.32%
|
O:
-1.02%
H:
0.0%
C:
0.0%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
13.18%
|
O:
0.49%
H:
0.47%
C:
-1.59%
BHC
|
$8.56
0.35%
0.0%
2M
|
Health Technology
|
-5.22%
|
O:
-0.89%
H:
0.67%
C:
-6.05%
RGNX
|
$16.05
0.94%
0.93%
350K
|
Health Technology
|
-29.83%
|
O:
-0.75%
H:
0.53%
C:
-3.07%
treatment
report
macular
market
Dementia and Movement Disorder Treatment Market: 45% of Growth to Originate from North America | By Drug Class and Geography - Forecast and Analysis 2022-2026
Published:
2022-05-11
(Crawled : 01:00)
- prnewswire.com
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
37.06%
|
O:
0.81%
H:
0.0%
C:
-0.09%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
16.95%
|
O:
0.27%
H:
1.2%
C:
-0.85%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
-4.76%
|
O:
-0.65%
H:
1.14%
C:
-1.14%
BHC
|
$8.56
0.35%
0.0%
2M
|
Health Technology
|
6.23%
|
O:
15.69%
H:
13.62%
C:
9.04%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
12.0%
|
O:
0.21%
H:
0.0%
C:
0.0%
BIIB
|
$201.91
4.52%
4.32%
3.3M
|
Health Technology
|
0.32%
|
O:
-0.15%
H:
3.04%
C:
-0.63%
america
treatment
dementia
drug
growth
← Previous
1
2
Next →
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.